Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 65.08% is in line with its 5-year average of 65.67%, around the middle of its 5-year range (63.80%–66.83%).
0.16% above its 12-month average of 64.97%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 65.35%.
GROSS MARGIN
65.08%
GROSS MARGIN AVG TTM
64.97%
GROSS MARGIN AVG 3Y
65.87%
GROSS MARGIN AVG 5Y
65.67%
GROSS MARGIN AVG 10Y
62.59%
GROSS MARGIN AVG 15Y
61.26%
GROSS MARGIN AVG 20Y
61.74%
CURRENT VS TTM AVG
+0.16%
CURRENT VS 3Y AVG
-1.20%
CURRENT VS 5Y AVG
-0.89%
CURRENT VS 10Y AVG
+3.98%
CURRENT VS 15Y AVG
+6.23%
CURRENT VS 20Y AVG
+5.41%
SECTOR MEDIAN · HEALTHCARE
43.54%
median of 609 covered companies
CURRENT VS SECTOR MEDIAN
+49.47%
vs the sector median at left
HealthStream, Inc.
Market Cap
$915.75M
Gross Margin
65.08%
TTM Avg
64.97%
3Y Avg
65.87%
5Y Avg
65.67%
Market Cap
$929.47M
Gross Margin
94.73%
TTM Avg
99.96%
3Y Avg
49.98%
5Y Avg
33.32%
Market Cap
$926.10M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$928.65M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$888.19M
Gross Margin
99.98%
TTM Avg
98.71%
3Y Avg
99.36%
5Y Avg
-14.89%
Market Cap
$863.62M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$979.81M
Gross Margin
97.19%
TTM Avg
61.28%
3Y Avg
80.64%
5Y Avg
87.09%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HealthStream, Inc. (HSTM) | $915.75M | 65.08% | 64.97% | 65.87% | 65.67% |
| Kura Oncology, Inc. (KURA)vs › | $929.47M | 94.73% | 99.96% | 49.98% | 33.32% |
| MoonLake Immunotherapeutics (MLTX)vs › | $926.10M | 0.00% | 0.00% | 0.00% | 0.00% |
| CeriBell, Inc. (CBLL)vs › | $929.41M | 88.90% | 87.31% | 85.47% | 85.47% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $928.65M | 100.00% | 100.00% | 100.00% | 100.00% |
| Bioventus Inc. (BVS)vs › | $894.82M | 68.00% | 67.52% | 65.94% | 67.78% |
| Arbutus Biopharma Corp (ABUS)vs › | $888.19M | 99.98% | 98.71% | 99.36% | -14.89% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $863.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| MeiraGTx Holdings plc (MGTX)vs › | $979.81M | 97.19% | 61.28% | 80.64% | 87.09% |
| Aktis Oncology, Inc. (AKTS)vs › | $983.42M | 100.00% | 100.00% | 50.00% | 50.00% |
Gross Margin
65.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 65.35% |
| 2026-03-31 | 65.82% |
| 2025-12-31 | 63.80% |
| 2025-09-30 | 65.34% |
| 2025-06-30 | 64.56% |
| 2025-03-31 | 65.32% |
| 2024-12-31 | 66.17% |
| 2024-09-30 | 66.52% |
| 2024-06-30 | 66.83% |
| 2024-03-31 | 66.17% |
| 2023-12-31 | 65.98% |
| 2023-09-30 | 66.47% |
| 2023-06-30 | 65.94% |
| 2023-03-31 | 65.40% |
| 2022-12-31 | 65.66% |
| 2022-09-30 | 65.26% |
| 2022-06-30 | 66.13% |
| 2022-03-31 | 66.35% |
| 2021-12-31 | 64.28% |
| 2021-09-30 | 64.76% |
| 2021-06-30 | 65.04% |
| 2021-03-31 | 64.16% |
| 2020-12-31 | 63.22% |
| 2020-09-30 | 61.73% |
| 2020-06-30 | 62.12% |
| 2020-03-31 | 66.93% |
| 2019-12-31 | 60.32% |
| 2019-09-30 | 59.41% |
| 2019-06-30 | 57.97% |
| 2019-03-31 | 58.79% |
| 2018-12-31 | 57.49% |
| 2018-09-30 | 58.11% |
| 2018-06-30 | 59.24% |
| 2018-03-31 | 59.44% |
| 2017-12-31 | 57.59% |
| 2017-09-30 | 57.94% |
| 2017-06-30 | 57.10% |
| 2017-03-31 | 56.11% |
| 2016-12-31 | 55.35% |
| 2016-09-30 | 57.36% |
| 2016-06-30 | 58.71% |
| 2016-03-31 | 57.65% |
| 2015-12-31 | 57.70% |
| 2015-09-30 | 57.04% |
| 2015-06-30 | 56.98% |
| 2015-03-31 | 57.18% |
| 2014-12-31 | 57.28% |
| 2014-09-30 | 57.07% |
| 2014-06-30 | 55.89% |
| 2014-03-31 | 55.86% |
| 2013-12-31 | 56.48% |
| 2013-09-30 | 58.13% |
| 2013-06-30 | 59.68% |
| 2013-03-31 | 57.77% |
| 2012-12-31 | 60.08% |
| 2012-09-30 | 59.04% |
| 2012-06-30 | 60.66% |
| 2012-03-31 | 59.55% |
| 2011-12-31 | 61.43% |
| 2011-09-30 | 61.61% |
| 2011-06-30 | 63.72% |
| 2011-03-31 | 61.80% |
| 2010-12-31 | 62.88% |
| 2010-09-30 | 62.24% |
| 2010-06-30 | 64.55% |
| 2010-03-31 | 63.19% |
| 2009-12-31 | 63.95% |
| 2009-09-30 | 61.66% |
| 2009-06-30 | 64.15% |
| 2009-03-31 | 61.32% |
| 2008-12-31 | 62.16% |
| 2008-09-30 | 62.28% |
| 2008-06-30 | 62.63% |
| 2008-03-31 | 60.36% |
| 2007-12-31 | 62.04% |
| 2007-09-30 | 63.28% |
| 2007-06-30 | 63.81% |
| 2007-03-31 | 64.02% |
| 2006-12-31 | 67.81% |
| 2006-09-30 | 68.21% |
| 2006-06-30 | 61.55% |
| 2006-03-31 | 65.77% |
| 2005-12-31 | 64.45% |
| 2005-09-30 | 64.98% |
| 2005-06-30 | 63.87% |
| 2005-03-31 | 64.17% |
| 2004-12-31 | 65.72% |
| 2004-09-30 | 64.71% |
| 2004-06-30 | 62.68% |
| 2004-03-31 | 61.49% |
| 2003-12-31 | 62.94% |
| 2003-09-30 | 67.71% |
| 2003-06-30 | 65.73% |
| 2003-03-31 | 66.14% |
| 2002-12-31 | 69.69% |
| 2002-09-30 | 66.75% |